iiinova — where your digital self keeps evolving

Molecular Oncology @moloncology.bsky.social · 21/09/2026

📣 Applications are now open for the @helloeacr.bsky.social EACR Molecular Oncology Editorial Fellowship! A great opportunity to gain experience of the editorial and peer-review process and learning more about academic publishing. 📅 Deadline: 11 November 2026 🔗 Apply: www.eacr.org/eacr-molecul...

011

Molecular Oncology @moloncology.bsky.social · 18/09/2026

To honor the 🎗️ Gynaecological and Urological Cancer Awareness Month, in our latest issue we present a collection of articles featuring pre-clinical research on pre-malignant and malignant conditions of the female reproductive system and urinary tract. 🔓: febs.onlinelibrary.wiley.com/toc/18780261...

000

Molecular Oncology @moloncology.bsky.social · 24/08/2026

📢 We are pleased to announce the Abstract Book of the EACR 2026 Congress is out in a Supplement of the latest issue of Molecular Oncology - affiliated journal of the helloeacr.bsky.social European Association for Cancer Research. 👉Read the abstracts: febs.onlinelibrary.wiley.com/toc/18780261...

000

Molecular Oncology @moloncology.bsky.social · 07/08/2026

🧠 Brain tumours are increasingly being viewed as dynamic ecosystems rather than isolated tumours. Explore the latest issue of Molecular Oncology, featuring new perspectives on brain tumour biology and research. Image credit: Dr Maialen Arrieta. 🔓 febs.onlinelibrary.wiley.com/toc/18780261...

000

Molecular Oncology @moloncology.bsky.social · 06/08/2026

📌One month on from the FEBS Congress we're looking back at the @febspress.bsky.social @helloeacr.bsky.social FEBS- EACR Special Session on "Molecular aspects of cancer" featuring Karin de Visser and Kevin Ryan. 💡Thanks to our speakers and everyone who joined us for this insightful session. 👏

010

Molecular Oncology @moloncology.bsky.social · 31/07/2026

🛎️ Interested in the newest discoveries in cancer metastasis? Consider registering and submitting an abstract for the upcoming #EESMetastasis Symposium! We are thrilled to support the event as media partners and look forward to seeing you there. #metastasis, #cancer, #CancerTherapy, #MeetTheEditor

022

Molecular Oncology @moloncology.bsky.social · 30/06/2026

🩸 A novel study from the Kasimir-bauer lab - University Hospital of Essen optimized the analysis of single circulating tumor cells in high-grade serous ovarian cancer to monitor genomic changes during treatment. Congratulations!👏 🔓https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70193

000

Molecular Oncology @moloncology.bsky.social · 30/06/2026

🔬 A novel study from the Villa lab at the Instituto do Câncer do Estado de São Paulo highlights IGFL2-AS1 as a promising biomarker that could improve the management of cervical adenocarcinoma. Congratulations! 👏 🔓https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70217

000

Molecular Oncology @moloncology.bsky.social · 26/06/2026

🔬 New research from the Taskén lab, Giusy Di Conza and colleagues show that roginolisib inhibits leukemic cells while preserving key T-cell functions, highlighting its potential as a safer alternative to current PI3K inhibitors. 🔓https://febs.onlinelibrary.wiley.com/doi/10.1002/1878-0261.70203

000

Molecular Oncology @moloncology.bsky.social · 25/06/2026

🧬 In a novel research study, researchers from @arkaitzcarracedo.bsky.social and Mendizabal labs at the @cicbiogune.bsky.social suggest that PTEN loss drives stromal remodeling programs that may help identify clinically aggressive tumors. Congrats! 👏 🔓: febs.onlinelibrary.wiley.com/doi/10.1002/...

021

Molecular Oncology @moloncology.bsky.social · 25/06/2026

🧪 Researchers from the lab of @ayeshashafi.bsky.social from @jeffersonuniv.bsky.social reported how pharmacologic ascorbate (vitamin C) enhances the efficacy of the PARP inhibitor olaparib in castration-resistant prostate cancer. Congratulations! 👏 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/...

000

Molecular Oncology @moloncology.bsky.social · 22/06/2026

🔬 Can we detect pancreatic cancer earlier? Researchers from Ryan lab at @cruk-si.bsky.social report a serum biomarker panel to distinguish pancreatic precursor lesions and early-stage pancreatic ductal adenocarcinoma, supporting early intervention. 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/...

010

Molecular Oncology @moloncology.bsky.social · 19/06/2026

📖 Researchers from the Warsaw University review emerging evidence on large-conductance calcium-activated potassium (BKCa) channels and their role in glioblastoma biology, highlighting the translational challenges of developing BKCa-targeted therapies. 👉 febs.onlinelibrary.wiley.com/doi/10.1002/....

000

Molecular Oncology @moloncology.bsky.social · 18/06/2026

🔬 From the latest issue: The Keiner lab at the @uni-jena.de investigated the role of the chloride cotransporter NKCC1 in glioblastoma as a prognostic marker, suggesting that restoring chloride homeostasis may represent a promising therapeutic strategy. 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/...

000

Molecular Oncology @moloncology.bsky.social · 17/06/2026

🔬 Researchers from the Jan Hahn group combined NIRL laser tissue sampling with lipidomics to identify lipid signatures to distinguish oropharyngeal squamous cell carcinoma from adjacent healthy tissue, supporting rapid molecular diagnostics. Full text: febs.onlinelibrary.wiley.com/doi/10.1002/...

010

Molecular Oncology @moloncology.bsky.social · 16/06/2026

➡️ What drives the anticancer activity of plecstatin in hepatocellular carcinoma? 📖 Researchers from the gregorlab.bsky.social at @imgprague.bsky.social identify plectin as key target of this metallodrug, dissecting its anti-tumor activity. 🔓 Full text: febs.onlinelibrary.wiley.com/doi/full/10....

010

Molecular Oncology @moloncology.bsky.social · 07/06/2026

💡 Can cancer be stopped before it starts? In a Viewpoint, researchers from the @charlesswanton.bsky.social lab discuss cancer interception, to prevent cancer before it develops. Could this be the next frontier in oncology? 🔓 febs.onlinelibrary.wiley.com/doi/10.1002/... #CancerPrevention #EACR

000

Molecular Oncology @moloncology.bsky.social · 05/06/2026

Our latest issue is out! 📣 🔍 We are pleased to present manuscripts showcasing a breadth of topics from insights into tumour evolution, new approaches to intercept cancer before it develops, and novel therapeutic targets in glioblastoma. 🔓 Full issue: febs.onlinelibrary.wiley.com/toc/18780261...

000

Molecular Oncology @moloncology.bsky.social · 02/06/2026

💡This week we highlight a study from the Jochen Utikal lab at @dkfz.bsky.social. 🧬Authors provide new insights into overcoming therapy resistance in melanoma, suggesting ERRFI1 as a potential target for treatment of metastatic melanoma.👏 ➡️ Full text: febs.onlinelibrary.wiley.com/doi/10.1002/...

000

Molecular Oncology @moloncology.bsky.social · 28/05/2026

🔬 Curious about mechanisms driving melanoma progression and metastasis? The Wolnicka-Głubisz lab identified RIPK4 as a regulator of melanoma cell adhesion and metastasis, highlighting its role as a modulator of tumour plasticity. 👏 🔓 Full text: febs.onlinelibrary.wiley.com/doi/10.1002/...

000

Molecular Oncology @moloncology.bsky.social · 21/05/2026

We’re thrilled to reveal the winners of the Molecular Oncology Writing Contest 2026! 🎉 🏆 Muhammad Habiburrahman 🥈 Alyssa Paparella 🥉 Ihsaan Jama ➡️ Read their essays on: febs.onlinelibrary.wiley.com/hub/journal/... 👏 Congratulations! Way to go! #SciComm #FEBS #WritingCommunity #OpenAccess

021

Molecular Oncology @moloncology.bsky.social · 19/05/2026

💡Interested in PD-L1 regulation in melanoma? 📖 A new study from the Annemiek van Spriel and colleagues identifies TSPAN4 as a negative regulator of PD-L1 in melanoma, uncovering a new layer of immune checkpoint regulation. 🔓 Read the full manuscript: febs.onlinelibrary.wiley.com/doi/10.1002/...

febs.onlinelibrary.wiley.com

FEBS Press

Using cell surface proximity biotinylation, we identified tetraspanin TSPAN4 within the PD-L1 interactome of melanoma cells. TSPAN4 negatively regulates PD-L1 expression and lateral mobility by limit...

000

Molecular Oncology @moloncology.bsky.social · 15/05/2026

💡 Join us in congratulating Michalis Gounis @gounismichalis.bsky.social postdoctoral researcher from @turkubioscience.bsky.social for winning the Best Oral Talk FEBS Molecular Oncology prize 🏆at FEBS 2026 Advanced Course on Tumour microenvironment in Fodele, Greece. Well done! 👏 #FEBS #FEBSPress

010

Molecular Oncology @moloncology.bsky.social · 11/05/2026

➡️ May Issue is out ❗ In support of #Melanoma and Skin Cancer Awareness Month, we present a collection of articles focused on melanoma. 📗Cover: Melanoma-secreted peroxidase enables immune escape by binding the NKG2D receptor on NK cells by Hsu-Min Sung et al. - pp 1161-1184. 🔓 buff.ly/TQtHfXU

buff.ly

FEBS Press

<em>Molecular Oncology</em> is an open access FEBS journal covering basic, translational, and clinical cancer research, as well as cancer diagnosis, prevention and care.

000

Molecular Oncology @moloncology.bsky.social · 26/03/2026

📚 New Review for your weekend reading! Liquid biopsy epigenetics: establishing a molecular profile based on cell-free DNA 🔓 buff.ly/4a4AmPZ #Epigenetics #LiquidBiopsy #CellFreeDNA #cfDNA

000

Reposted by Molecular Oncology

EACR - European Association for Cancer Research @helloeacr.bsky.social · 02/02/2026

Are you an early career researcher attending #EACR2026? You're invited to our early career showcase, Cancer Researchers to Watch, taking place 7-8 June! Learn more: 2026.eacr.org/cancer-resea...

045

Reposted by Molecular Oncology

EACR - European Association for Cancer Research @helloeacr.bsky.social · 19/01/2026

Registration is OPEN for the cancer research community to join us for the #EACR2026 Congress! 🥳 Don't miss the opportunity to take advantage of our discounted early registration rate to attend, available until 21 April. 2026.eacr.org

01315

Reposted by Molecular Oncology

EACR - European Association for Cancer Research @helloeacr.bsky.social · 04/02/2026

Join us in congratulating Amel Aziba on being selected as the third recipient of an EACR - @moloncology.bsky.social Editorial Fellowship! Learn more about Amel and the Fellowship: magazine.eacr.org/amel-aziba-r...

111

Molecular Oncology @moloncology.bsky.social · 05/02/2026

📘 We are pleased to share our new Thematic issue: European Code Against Cancer – 5th Edition #ECAC5. 🌐ECAC5 provides public health recommendations, and its effective implementation could prevent up to 40% of new cancers in the EU. 👉 Find out more here: febs.onlinelibrary.wiley.com/toc/18780261...

021

Molecular Oncology @moloncology.bsky.social · 04/02/2026

🎗️In support of #WorldCancerDay, Molecular Oncology invites cancer researchers to take part in a writing competition aimed at envisioning a landscape in the year 2050 where #CancerPrevention is as transformative as cancer treatment. ✍ Further details: febs.onlinelibrary.wiley.com/hub/journal/...

000

Molecular Oncology @moloncology.bsky.social · 22/12/2025

As we wrap up 2025, we look back with gratitude on the outstanding 12 issues we have put together this year—made possible by your support. Here's to a year of impactful science and collaboration. Wishing you a joyful holiday season 🧑‍🎄 and a prosperous New Year ahead. 💥 #HappyHolidays #HappyNewYear

010

Molecular Oncology @moloncology.bsky.social · 16/12/2025

🔦 Have you seen our latest Commentary? TREX1, a predator for treating MSI-H tumors? 🔓 buff.ly/MAOG3pB #cGASSTING #ImmuneEvasion #CancerResearch

020

Molecular Oncology @moloncology.bsky.social · 12/12/2025

Next-generation proteomics improves lung cancer risk prediction ➡️ buff.ly/HuGy5mW #Proteomics #LungCancer #CancerRisk #MassSpec

010

Molecular Oncology @moloncology.bsky.social · 11/12/2025

📢Call for papers 📭Submit your latest research in the field of #LiquidBiopsy ➡️Format: Research Article, Short Report or Method ➡️Details buff.ly/ATND9t1 #ACTC2025 #CTC #ctDNA #Cancer

010

Molecular Oncology @moloncology.bsky.social · 10/12/2025

Monitoring of circulating tumor DNA allows early detection of disease relapse in patients with operable breast cancer 👉 buff.ly/eiXX4Km #ctDNA #BCSM #LiquidBiopsy

000

Molecular Oncology @moloncology.bsky.social · 09/12/2025

📣 New Commentary available A subset of MMR-proficient colon cancers responds to neoadjuvant immunotherapy 🔓 buff.ly/DD6XMCS 🖊️ @Albert0Bardelli #ctDNA #TME #ColonCancer

000

Molecular Oncology @moloncology.bsky.social · 08/12/2025

🛠️ New Method online! Molecular characterisation of human penile carcinoma and generation of paired epithelial primary cell lines 👉 buff.ly/plPVqud 🖊️ @Dr_Andrology #Urology #UrOnc #Wntsignaling

000

Molecular Oncology @moloncology.bsky.social · 04/12/2025

🤝 In conjunction with the recent @helloeacr.bsky.social conference on #CancerNeuroscience we have an active call for papers! 📩 Submit your latest Research Article, Short Report or Method in the field of #BrainTumours #CNStumours #NeuroOncology 👉 More details buff.ly/OfzaVDe

022

Molecular Oncology @moloncology.bsky.social · 02/12/2025

Methylation biomarkers can distinguish pleural mesothelioma from healthy pleura and other pleural pathologies 🔦 buff.ly/jhH0yQu #CancerBiomarkers #PleuralMesothelioma #DNAmethylation

000

Molecular Oncology @moloncology.bsky.social · 01/12/2025

New Policy article now available European Code Against Cancer, 5th edition – hormone replacement therapy, other common medical therapies and cancer 🔓 buff.ly/Ch17N9f #HormoneReplacementTherapy #HormonalContraceptive #Aspirin

000

Molecular Oncology @moloncology.bsky.social · 28/11/2025

Cytoplasmic p21 promotes stemness of colon cancer cells via activation of the NFκB pathway 👉 buff.ly/AOrrON6 #p21 #ColonCancer #Stemness #NFκB

010

Molecular Oncology @moloncology.bsky.social · 27/11/2025

🔍 We are looking for papers! 📩 Submit your latest research in the field of #CancerImmunology #ImmunoOnc 🖊️ Whether it is a Research Article, Short Report or Method, your paper would be suitable! 👉 Find out more details buff.ly/ZDb3rO0

000

Molecular Oncology @moloncology.bsky.social · 26/11/2025

Dual targeting of RET and SRC synergizes in RET fusion-positive cancer cells 🔦 buff.ly/wj2wwUX @EmilianoCocco2 #NSCLC #RETfusion #FusionProtein

000

Molecular Oncology @moloncology.bsky.social · 25/11/2025

Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication 👉 buff.ly/3RjSDs7 🖊️ @imendizabal1 @ArkaitzLab #PTEN #PCSM #TumourMicroenvironment #TumorStroma

000

Molecular Oncology @moloncology.bsky.social · 24/11/2025

📑 New Review for your reading list Cis-regulatory and long noncoding RNA alterations in breast cancer – current insights, biomarker utility, and the critical need for functional validation 🔓 buff.ly/g5WeXxC @Dr_Alex_Eustace #ncRNA #BCSM #Biomarkers

000

Molecular Oncology @moloncology.bsky.social · 21/11/2025

Detection of circulating tumor DNA in colorectal cancer patients using a methylation-specific droplet digital PCR multiplex 🔓 buff.ly/CG0J1Ck #ctDNA #ddPCR #CRC #Epigenetics #CancerDiagnostics #Biomarkers

000

Molecular Oncology @moloncology.bsky.social · 20/11/2025

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107 🔦 buff.ly/hlA2obL #PARPi #BladderCancer #BRCA #

010

Molecular Oncology @moloncology.bsky.social · 19/11/2025

Effect of chemotherapy on passenger mutations in metastatic colorectal cancer 👉 buff.ly/WGihs9T #Chemotherapy #Metastasis #CRCSM

000

Molecular Oncology @moloncology.bsky.social · 18/11/2025

🚨 New Review alert - don't miss this Strength through diversity: how cancers thrive when clones cooperate 🔓 buff.ly/kQAi97p #TumourHeterogeneity #TherapyResistance #CancerResistance

000

Molecular Oncology @moloncology.bsky.social · 18/11/2025

🚨 New Review alert - don't miss this Strength through diversity: how cancers thrive when clones cooperate 🔓 buff.ly/kQAi97p #TumourHeterogeneity #TherapyResistance #CancerResistance

000